Cardiac Synchronization Technology for PEA Patients

Information

  • Research Project
  • 7282235
  • ApplicationId
    7282235
  • Core Project Number
    R43HL080826
  • Full Project Number
    7R43HL080826-02
  • Serial Number
    80826
  • FOA Number
    PA-04-59
  • Sub Project Id
  • Project Start Date
    8/19/2005 - 19 years ago
  • Project End Date
    5/31/2007 - 17 years ago
  • Program Officer Name
    BALDWIN, TIM
  • Budget Start Date
    8/19/2006 - 18 years ago
  • Budget End Date
    5/31/2007 - 17 years ago
  • Fiscal Year
    2005
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/22/2006 - 18 years ago

Cardiac Synchronization Technology for PEA Patients

[unreadable] DESCRIPTION (provided by applicant): Pulseless electrical activity (PEA) also referred to as electromechanical dissociation (EMD), has been described as "the presence of organized electrical activity on the electrocardiogram but without palpable pulses." It is the common end-point for a number of processes that interfere with cardiopulmonary function, in particular major cardiac insults and respiratory failure with hypoxia. The vast majority of patients suffering PEA in the out-of-hospital setting will not survive. Therefore, an effective treatment for PEA could be extraordinarily important. Previous research has demonstrated that a large fraction of patients in PEA actually have residual cardiac mechanical activity. The research team has developed a hypothesis that outcomes may improve if cardiac compressions are synchronized with residual myocardial mechanical activity. In other words, we hypothesize that outcomes will improve if compressions are timed to assist ejection -- squeezing the chest during intrinsic contractions -- and relaxing so as to allow adequate ventricular filling during intrinsic diastole. In response to NIH Program Announcement (PA) 04-059 - Technologies for Monitoring and Performing Resuscitation, Rose Biomedical Development Corporation proposes to develop and pilot test Cardiac Synchronization Technology (CST), a non-invasive approach to improving outcomes by synchronizing chest compression with residual cardiac mechanical activity in patients with pseudo-EMD PEA. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    54343
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:54343\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    QUEST PRODUCT DEVELOPMENT CORPORATION
  • Organization Department
  • Organization DUNS
    958218406
  • Organization City
    Arvada
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    80007
  • Organization District
    UNITED STATES